B. Riley raised the firm’s price target on Diversified Healthcare Trust (DHC) to $5.50 from $4.50 and keeps a Buy rating on the shares. The company’s greater capital flexibility post the debt pricing offsets headwinds to 2026 earnings estimates from higher interest expense, the analyst tells investors in a research note. The firm now sees certainty for Diversified’s January repaymet.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DHC:
- Diversified Healthcare Trust Sells Senior Living Management
- Diversified Healthcare Trust reports sale by AlerisLife of 116 management pacts
- Diversified Healthcare Trust’s Optimistic Earnings Call Highlights
- Diversified Healthcare Trust Reports Q2 2025 Results
- Diversified Healthcare Trust (DHC) Q2 Earnings Cheat Sheet